In this study, transient knockdown of DR4 gene expression caused apoptosis and further enhanced osimertinib-induced apoptosis in the sensitive EGFRm NSCLC cells, whereas enforced DR4 expression in these cells significantly attenuated osimertinib-induced apoptosis. This evidence concerns the gene TNFRSF10A and non-small cell lung carcinoma.